Welcome to European Tribune. It's gone a bit quiet around here these days, but it's still going.
J&J[/Janssen] files COVID-19 vaccine application with U.S. FDA
  • 66% effective
  • no freezer
  • single dose
  • conventional conjugate (inactive adenovirus 26)
  • competitively priced
The United States has agreed to pay $1 billion for 100 million doses, which J&J said it expected to supply in the first half of the year. The United States also has the option of purchasing an additional 200 million doses.

The company said it has doses ready for delivery upon emergency approval. It aims to deliver 1 billion doses in 2021 with production in the United States, Europe, South Africa and India.

by Cat on Fri Feb 5th, 2021 at 12:03:03 AM EST
[ Parent ]

Others have rated this comment as follows:


Occasional Series